Faq

FAQ’S ABOUT IBOGAINE TREATMENT

How effective is Ibogaine? Ibogaine is highly regarded as a powerful interrupter for substance dependence, particularly for opiate use disorder. While it is not a “magic cure,” data and clinical experience over the last decade suggest it can significantly reduce acute withdrawal symptoms and post-acute withdrawal cravings. When paired with proper aftercare and integration, ibogaine provides a critical window of opportunity for individuals to achieve long-term sobriety.

What should I expect from the Ibogaine treatment? Clients typically begin to feel the effects within an hour of administration. The active phase is often described as an “introspective, dream-like state” (oneirophrenic). During this time, patients frequently experience a rapid processing of past trauma, repressed memories, and the root causes of their dependence. This profound psychological reset helps many guests process feelings of guilt, shame, and anger, allowing them to move forward with a renewed sense of purpose and clarity.

How long does the experience last? The most intense, introspective phase of the treatment typically lasts between 12 to 24 hours. This is usually followed by a 24-hour “gray day” or processing period, where the body rests and the mind begins to integrate the experience.

Will I still experience cravings or withdrawal afterward? Ibogaine is uniquely effective at mitigating severe opioid withdrawal symptoms and resetting neural pathways to drastically reduce cravings. However, patients may still experience mild residual symptoms, such as fatigue or low energy, in the days following treatment. Our medical team is equipped to mitigate these mild reactions with supportive care and short-acting medications as needed.

What does the Ibogaine by David Dardashti program include? Our program is a comprehensive, medically supervised protocol. Upon arrival, the initial days are dedicated to intake, acclimatization, and vital pre-screening (including EKGs, blood panels, and psychological evaluations). Please note: Treatment timelines are highly individualized. While some guests may be cleared for treatment within the first few days, individuals transitioning from long-acting substances (like methadone or fentanyl) will require a longer, carefully managed stabilization period to ensure safety. We generally recommend guests plan for a minimum of 7 to 14 days at our facility.

Is there any follow-up care? Absolutely. The work does not stop when the active treatment ends. Ibogaine provides the reset, but integration maintains it. Our follow-up protocol includes ongoing phone support, guidance for continuing therapy, and access to a network of alumni. We strongly encourage our guests to stay connected and remain accountable as they build their new lives.

What conditions can Ibogaine treat? At Ibogaine by David Dardashti, we specialize in utilizing ibogaine to interrupt substance use disorders, including dependencies on heroin, cocaine, methamphetamine, and short-acting opiates. Additionally, it has shown profound promise in helping individuals process severe trauma, depression, and PTSD. (Note: Ibogaine is not suitable for everyone. Conditions such as schizophrenia, active psychosis, and bipolar disorder are strict contraindications for this treatment.)

Is the treatment safe? When administered in a controlled clinical setting, the risks associated with ibogaine can be effectively managed. However, ibogaine does carry serious cardiovascular risks, specifically the potential to alter heart rhythms (QT prolongation). Because of this, treatment is only safe when overseen by experienced medical professionals. We utilize rigorous pre-screening, continuous real-time cardiac monitoring, and ACLS-certified staff to ensure the highest standards of patient safety.

Accessibility Toolbar

Translate »